Brokerage firm Baird Downgrades its rating on MEDNAX Inc(MD). The shares have been rated Neutral. Previously, the analysts had a Outperform rating on the shares. The rating by the stock financial advisor at Baird was issued on Mar 21, 2017 in a research report to their Investors and Clients.
In a different note, On Mar 10, 2017, JP Morgan said it Downgrades its rating on MEDNAX Inc. The shares have been rated ‘Neutral’ by the firm.
MEDNAX Inc (MD) made into the market gainers list on Fridays trading session with the shares advancing 2.15% or 1.46 points. Due to strong positive momentum, the stock ended at $69.27, which is also near the day’s high of $69.675. The stock began the session at $67.99 and the volume stood at 7,45,611 shares. The 52-week high of the shares is $76.96 and the 52 week low is $59.36. The company has a current market capitalization of $6,434 M and it has 9,28,89,873 shares in outstanding.
MEDNAX Inc(MD) last announced its earnings results on Feb 7, 2017 for Fiscal Year 2016 and Q4.Company reported revenue of $830.770M. Analysts had an estimated revenue of $842.150M. Earnings per share were $1. Analysts had estimated an EPS of $1.06.
Several Insider Transactions has been reported to the SEC. On Mar 17, 2017, Dominic J Andreano (SVP, General Counsel and Secy) sold 6,517 shares at $70.84 per share price.Also, On Feb 24, 2017, Enrique Sosa (director) sold 10,668 shares at $69.65 per share price.On Feb 17, 2017, Vivian Lopez-blanco (Chief Financial Officer) sold 15,164 shares at $70.01 per share price, according to the Form-4 filing with the securities and exchange commission.
MEDNAX Inc. (MEDNAX) is a provider of physician services including newborn maternal-fetal and other pediatric subspecialty care. The Company provides clinical care to babies born prematurely or with complications within specific hospital units primarily neonatal intensive care units (NICUs). It provides anesthesia care at more than 90 hospitals 100 ambulatory surgery centers and office-based practices with over 950 of its affiliated anesthesiologists. It provides acute and chronic pain management services in over 20 pain management centers through its network of physicians and physician assistants. It provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its over 245 affiliated maternal-fetal medicine subspecialists as well as obstetricians and other clinicians. Its network includes other pediatric subspecialists such as pediatric intensivists pediatric hospitalists and pediatric surgeons.